Nexalin Technology, Inc. balance sheet NXL

Annual Quarterly

As of Jun 30, 2026, Nexalin Technology, Inc. had total assets of $3.0 million and total liabilities of $1.5 million. Total assets were down 54.2% from a year earlier. Stockholders' equity was $1.5 million. Cash and investments were $4.1 million. The current ratio, current assets divided by current liabilities, was 1.25.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022
Assets
Cash	1 +133.0%	1 +14.0%	1 -1.0%	1 +256.5%	0
Short-term investments	3 -42.8%	3 +5.6%	3 +22.7%	2 -65.3%	7
Cash and investments	4 -29.7%	4 +7.0%	3 +18.0%	3 -57.8%	7
Receivables	0 -11.5%	0 +525.4%	0 +39.2%	0 +92.2%	0
Inventory	0 +35.0%	0 -24.7%	0 +11.6%	0 +1.3%	0
Total current assets	2 -70.3%	4 +8.5%	4 +15.5%	3 -53.8%	7
Property and equipment, net	0	—	—	—	0
Total assets	3 -54.2%	5 +9.8%	4 +16.3%	4 -51.1%	7
Liabilities and equity
Accounts payable	0 -0.5%	0 +56.8%	0 -2.2%	0 -75.8%	1
Total current liabilities	1 +147.2%	1 +62.3%	1 +28.5%	0 -78.2%	2
Total liabilities	1 +147.2%	1 +62.3%	1 +28.5%	0 -78.2%	2
Stockholders' equity	2 -74.5%	4 +2.0%	4 +14.6%	3 -41.5%	5
Debt
Lease liabilities	—	—	—	0 -91.9%	0
Total debt	—	—	—	0 -91.9%	0
Net cash	—	—	—	3 -57.6%	7
Ratios
Current ratio	1.25x	4.85x	7.25x	8.07x	3.81x
Debt to equity	—	—	—	0.00x	0.01x
Return on equity	-591.60%	-219.38%	-206.94%	-144.97%	-30.99%
Return on assets	-299.21%	-177.38%	-180.15%	-128.00%	-22.84%
Book value per share	0.07	0.20	0.28	0.43	0.75

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: NXL (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Houston, TX
SEC filer status: , Emerging growth company
SEC CIK: 1527352

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.